DCW Ltd

- No immediate plans to repay debt; the company prefers to let debt reduce naturally through scheduled repayments (125 crores this year). - Current gross debt stands at approximately 504 crores, with cash balances around 160 crores, resulting in net debt of about 340 crores. - Management indicates the cost of borrowing has significantly reduced to sub-10% from around 17%. - There is no explicit mention of new fundraising through debt or equity in the current period. - Future decisions on debt repayment or new funding will depend on upcoming CAPEX requirements and growth projects, especially after completion of ongoing projects. - The company is considering internal accruals to fund future CAPEX. - No clear indication of equity fundraising or fresh debt issuance at present; the focus is on managing existing financial resources efficiently.

- Current announced CAPEX is around ₹125 crores for doubling CPVC capacity and debottlenecking SIOP, with about ₹60 crores spent as of March 31 and 70% work done; some cost savings anticipated. - Additional balance CAPEX of around ₹60 crores is required to complete announced projects. - Routine CAPEX is about ₹30-40 crores. - Total expected CAPEX spend including routine and announced projects for the year is around ₹100 crores. - Future CAPEX includes making the Sahupuram facility chlorine neutral as part of ESG initiatives. - Management is exploring renewable energy options like solar to reduce energy costs and carbon footprint. - After completing current projects, the company plans to evaluate the next growth driver for FY25, including possible geographic de-risking and further expansion. - Debt repayment decisions (₹125 crores repayment planned this year) will depend on CAPEX requirements and internal accruals.

- CPVC and SIOP segments expected to grow with strong demand; CPVC demand is growing in double digits, especially in lower-tier cities and rural India. - SIOP capacity utilization increased to ~80% with consistent growth in revenues and margins; plans to expand footprint in European markets. - Specialty chemicals to maintain margins north of 35% with increasing volumes starting Quarter 2 and Quarter 3. - Commodity chemicals like caustic soda prices seen as bottomed out; expected recovery as China's domestic demand improves. - Overall volumes expected to increase with capacity additions in CPVC and SIOP, providing annualized EBITDA north of ₹220 crores post capex. - Margins across segments expected to be maintained, with some quarter-to-quarter fluctuations due to price moves. - Company targets a balanced portfolio between specialty and commodity chemicals for sustainable margin protection.

- Annualized profit from CPVC and SIOP capacity expected to be north of ₹200 crores post capacity coming online; current year will see partial benefit (Page 16). - Specialty chemicals (SIOP and CPVC) projected EBITDA: ₹115 crores this year and over ₹220 crores next year post capex (Page 14). - EBITDA margin for CPVC and SIOP expected to remain north of 35% on increased volumes (Page 6). - Total EBITDA expected to exceed ₹200 crores with contributions from PVC (5-7% margin), caustic (3-4% margin), and soda ash segments (Page 15). - EPS expected to grow with increased volumes and profitability in specialty chemicals and stabilization/recovery in commodity chemicals (implied across pages). - Interest cost reduction and strong free cash flow to support profitability; no immediate debt repayment planned, allowing internal accruals to fund growth (Page 14 & 9). - Long-term growth guided by capacity expansions, specialty chemical focus, and trading volumes (Pages 13, 11).

- The transcript does not explicitly mention the current or expected order book or pending orders. - However, there is an indication of growth and positive demand in segments like CPVC and SIOP, with capacity expansions underway and expected volume ramp-up starting Q3 FY24. - The company anticipates maintaining strong margins above 35% for specialty chemicals (SIOP and CPVC) with increased volumes. - Discussions show confidence in sustaining or improving EBITDA supported by additional volumes despite price corrections. - Management indicated stable operations with no mention of any backlog or pending orders causing concern. - The company is focused on completing announced projects quickly to support the next phase of growth, implying active order flow and production ramp-up aligned with capacity expansions. No direct order book numbers are provided in the transcript on page 17 or surrounding pages.